2476 - 2500 of 6570 Results
Title
Year
-
OPENTitle: Multimodal MRI evaluation of parkinsonian limbic pathologiesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 76Issue #:Start Page: 194End Page: 200Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.01.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6461740Citation Count: 15
-
OPENTitle: Intact working memory in non‐manifesting LRRK2 carriers – an fMRI studyJournal Name: European Journal of NeurosciencePublisher: WileyVol: 43Issue #: 1Start Page: 106End Page: 112Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.13120Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13120Citation Count: 20
-
OPENTitle: Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 69Issue #:Start Page: 263End Page: 275Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.05.012Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4135465Citation Count: 34
- Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse Model2023OPENTitle: Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse ModelJournal Name: Annals of NeurologyPublisher: WileyVol: 93Issue #: 5Start Page: 881End Page: 892Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26600Citation Count: 15
-
OPENTitle: Holmes Tremor‐Like Phenotype in DYT1 DystoniaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 206End Page: 208Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12585Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12585Citation Count: 3
-
OPENTitle: Exploring the layers of fatigue in Parkinson’s Disease: A comprehensive analysis of its prevalence and contributing factorsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 11Issue #:Start Page: 100288End Page: 100288Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100288Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100288Citation Count: 3
-
OPENTitle: Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson’s disease patients with defined cholinergic lossesJournal Name: NeuroImagePublisher: Elsevier BVVol: 149Issue #:Start Page: 295End Page: 304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.02.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5386784Citation Count: 50
-
OPENTitle: Essential Tremor and DepressionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 6Start Page: 838End Page: 842Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12530Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12530Citation Count: 13
-
OPENTitle: Stimulation-induced reversed plus-minus syndrome: Insights into eyelid physiologyJournal Name: Brain StimulationPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 951End Page: 952Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2018.04.010Best OA location URL: https://doaj.org/article/b711f7d9567240b89145b894bc21f1beCitation Count: 3
-
OPENTitle: Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervationJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 123Issue #: 4Start Page: 421End Page: 424Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-016-1524-7Best OA location URL: http://doi.org/10.1007/s00702-016-1524-7Citation Count: 30
-
OPENTitle: Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacyJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 12Start Page: 2915End Page: 2919Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.04.041Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4899947Citation Count: 3
-
OPENTitle: Combating Parkinson’s disease-associated toxicity by modulating proteostasisJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 114Issue #: 5Start Page: 803End Page: 804Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1620082114Best OA location URL: https://www.pnas.org/content/pnas/114/5/803.full.pdfCitation Count: 6
-
OPENTitle: Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: Gene and smoking status interactionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 72End Page: 76Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.07.007Best OA location URL: https://zenodo.org/record/3421671Citation Count: 28
-
OPENTitle: Glucagon‐like Peptides (GLP‐1) Perspectives in Synucleinopathies TreatmentJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 3Start Page: 255End Page: 258Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12611Citation Count: 7
-
OPENTitle: Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetesJournal Name: Pharmacoepidemiology and Drug SafetyPublisher: WileyVol: 31Issue #: 8Start Page: 875End Page: 882Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pds.5448Best OA location URL: https://doi.org/10.1002/pds.5448Citation Count: 19
-
OPENTitle: Effect of the mGlu2 receptor positive allosteric modulator AZD8529 on L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmosetJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 1005Issue #:Start Page: 178031End Page: 178031Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ejphar.2025.178031Best OA location URL: https://doi.org/10.1016/j.ejphar.2025.178031Citation Count: 0
-
OPENTitle: A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stageJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 213Issue #:Start Page: 107018End Page: 107018Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2025.107018Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107018Citation Count: 2
-
OPENTitle: Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 19Issue #:Start Page: 1025End Page: 1035Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2018.05.006Best OA location URL: https://doi.org/10.1016/j.nicl.2018.05.006Citation Count: 66
- Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?2023OPENTitle: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?Journal Name: Environment InternationalPublisher: Elsevier BVVol: 173Issue #:Start Page: 107852End Page: 107852Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envint.2023.107852Best OA location URL: https://doi.org/10.1016/j.envint.2023.107852Citation Count: 1
- Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study2017OPENTitle: Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset studyJournal Name: Schizophrenia ResearchPublisher: Elsevier BVVol: 214Issue #:Start Page: 3End Page: 10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.schres.2017.11.038Citation Count: 86
-
OPENTitle: Distal Covalent Targeting Suppresses Signaling of Oncogenic K-Ras(G13C) in Cancer CellsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 20Issue #: 7Start Page: 1696End Page: 1706Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschembio.5c00249Best OA location URL: https://doi.org/10.1021/acschembio.5c00249Citation Count: 3
-
OPENTitle: Neuron-derived extracellular vesicles to examine brain mTOR target engagement with sirolimus in patients with multiple system atrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 115Issue #:Start Page: 105821End Page: 105821Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105821Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10592064/pdf/nihms-1927641.pdfCitation Count: 9
-
OPENTitle: Impact of inpatient mobility on outcomes in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 135Issue #:Start Page: 107834End Page: 107834Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107834Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.107834Citation Count: 1
-
OPENTitle: Joint pattern analysis applied to PET DAT and VMAT2 imaging reveals new insights into Parkinson's disease induced presynaptic alterationsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 23Issue #:Start Page: 101856End Page: 101856Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2019.101856Best OA location URL: https://doi.org/10.1016/j.nicl.2019.101856Citation Count: 29
-
OPENTitle: β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 357Issue #: 6354Start Page: 891End Page: 898Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.aaf3934Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5761666Citation Count: 438